/Sponsor / Executive Profile

Andrew Kucharchuk

Executive

Aggregate Capital Deployment Matrix

Active/Searching: $200M (55.9%)

Professional Biography

Andrew “Al” Kucharchuk has served as the Chief Financial Officer since October 2024.

Total Capital Deployed

$358,100,000

Active / Searching Capital:
$200,000,000

Transaction Volume

2 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

50.0%

Professional Network Intelligence

Frequent Underwriters

Frequent Associates

Top Sectors

  • Immunotherapy1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
RNGT
Range Capital Acquisition Corp II
searching
200.0M
$10.00
1/2Sep 2025
17mo
-GeneralBTIG, LLC
CERO
Phoenix Biotech Acquisition Corp.
closed
158.1M
$2.00
1/2Sep 2021Done-ImmunotherapyCantor Fitzgerald & Co.